Ligand Pharmaceuticals stock is on the rise with optimistic analyst ratings and a plan for 20% annual revenue growth. Learn ...

In their study, published in the journal Nature, the group came upon the idea of introducing para-toluenesulfonyl hydrazide (PTSH) as a stabilizing ligand to promote the formation of films during ...